A case of wild-type transthyretin cardiac amyloidosis with rheumatoid arthritis

References

• Nakamura T. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis. Mod Rheumatol. 2008;18(2):109–118.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361–2371.
   PubMed Web of Science ®Google Scholar
• Okuda Y, Yamada T, Ueda M, et al. First nationwide survey of 199 patients with amyloid A amyloidosis in Japan. Intern Med. 2018;57(23):3351–3355.
   Web of Science ®Google Scholar
• Okuda Y, Ohnishi M, Matoba K, et al. Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases. Mod Rheumatol. 2014;24(1):137–143.
   PubMed Web of Science ®Google Scholar
• Okuda Y. AA amyloidosis – benefits and prospects of IL-6 inhibitors. Mod Rheumatol. 2019;29(2):268–274.
   PubMed Web of Science ®Google Scholar
• Miyagawa I, Nakayamada S, Saito K, et al. Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis. Mod Rheumatol. 2014;24(3):405–409.
   PubMed Web of Science ®Google Scholar
• Sueyoshi T, Ueda M, Jono H, et al. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol. 2011;42(9):1259–1264.
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Yazaki M, Ueda M, et al. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan. Amyloid. 2018;25(1):8–10.
   PubMed Web of Science ®Google Scholar
• Kitaoka H, Izumi C, Izumiya Y, et al., Japanese Circulation Society Joint Working Group. JCS 2020 Guideline on diagnosis and treatment of cardiac amyloidosis. Circ J. 2020;84(9):1610–1671.
   Web of Science ®Google Scholar
• Nuvolone M, Merlini G. Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis. Expert Opin Ther Targets. 2017;21(12):1095–1110.
   PubMed Web of Science ®Google Scholar
• Wada Y, Kobayashi D, Murakami S, et al. Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents. Scand J Rheumatol. 2011;40(5):402–404.
   PubMed Web of Science ®Google Scholar
• Elghetany MT, Saleem A. Methods for staining amyloid in tissues: a review. Stain Technol. 1988;63(4):201–212.
   PubMed Web of Science ®Google Scholar
• Ando Y, Ueda M. Amyloidosis – state of the art 2017. Ishiyaku Publishers; 2017. Japanese.
   Google Scholar
• The group for surveys and research of amyloidosis in Japan fbt, Ministry of Health LaW, Japan. The 2010 guideline for the treatment of amyloidosis. 2010. Japanese.
   Google Scholar
• Tsukada T, Tanaka M, Miyazaki Y, et al. A case of unilateral shoulder joint hydrarthrosis with wild-type amyloidogenic transthyretin amyloidosis. Mod Rheumatol Case Rep. 2020;4(2):312–317.
   PubMedGoogle Scholar
• Grogan M, Scott CG, Kyle RA, et al. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol. 2016;68(10):1014–1020.
   PubMed Web of Science ®Google Scholar
• Connors LH, Sam F, Skinner M, et al. Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study. Circulation. 2016;133(3):282–290.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007–1016.
   PubMed Web of Science ®Google Scholar
• Gertz M, Adams D, Ando Y, et al. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Fam Pract. 2020;21(1):198.
   PubMed Web of Science ®Google Scholar
• Shinoda K, Taki H, Obayashi K, et al. Wild-type ATTR amyloidosis of the ureter in a 56-year-old woman with rheumatoid arthritis and Sjögren’s syndrome. Int J Clin Exp Path. 2015;8(7):8624–8627.
   Web of Science ®Google Scholar
• Ueda M, Horibata Y, Shono M, et al. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study. Modern pathology: an official journal of the United States and Canadian Academy of Pathology. Mod Pathol. 2011;24(12):1533–1544.
   PubMed Web of Science ®Google Scholar
• Ni M, Wei W, Feng Q, et al. Transthyretin as a potential serological marker for the diagnosis of patients with early rheumatoid arthritis. Clin Exp Rheumatol. 2013;31(3):394–399.
   PubMed Web of Science ®Google Scholar
• Matsuzaki T, Akasaki Y, Olmer M, et al. Transthyretin deposition promotes progression of osteoarthritis. Aging Cell. 2017;16(6):1313–1322.
   Web of Science ®Google Scholar
• Hamer JP, Janssen S, van Rijswijk MH, et al. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis. Eur Heart J. 1992 May;13(5):623–627.
   Web of Science ®Google Scholar
• Dubrey SW, Cha K, Skinner M, et al. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart. 1997;78(1):74–82.
   Web of Science ®Google Scholar
• Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404–2412.
   PubMed Web of Science ®Google Scholar
• Sidiqi MH, McPhail ED, Theis JD, et al. Two types of amyloidosis presenting in a single patient: a case series. Blood Cancer J. 2019;9(3):30.
   PubMedGoogle Scholar
• Hoshii Y, Takahashi M, Ishihara T, et al. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis. Pathol Int. 1994 May;44(5):352–358.
   Web of Science ®Google Scholar
• Immonen K, Finne P, Grönhagen-Riska C, et al. A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland. Amyloid. 2011;18(1):25–28.
   PubMed Web of Science ®Google Scholar